"I’ve never thought of it as a disability, but I can see that there’s a part of me that is like that," said David Byrne on ...

Honesty and flexibility are key to success, say leaders of Fraser’s unique services for people with autism who are battling ...

Psychiatric disorders such as schizophrenia, bipolar disorder, depression, and autism spectrum disorders present a significant global health burden, with ...

Re “ In New Focus on Autism, Some Worry the Spectrum Is Too Broad ” (front page, Oct. 5): One thing’s for certain: The autism label will continue to evolve as we learn more about what we currently ...

Background: Autism spectrum disorder (ASD) ranks among the leading causes of years lived with disability in adolescence and young adulthood (AYA), yet global assessments still focus on childhood and ...

Source: Lloyd, D. & Light, A. (2025). Masking Authentic Self and Autism. Google Gemini [Generative AI]. In episode 10 of the Breaking Through Therapy Podcast, we spoke with autism coach “Alfi” and ...

The FDA has approved an expanded indication for risperidone (Uzedy, Teva) extended-release injectable suspension, allowing it to be used for the maintenance treatment of bipolar I disorder in adults, ...

What Is Uzedy, and Why Does It Matter? Uzedy is a long-acting injectable form of risperidone, a medicine used to treat serious mental health conditions like schizophrenia and bipolar I disorder (BD-I) ...

Depression is characterized by a persistent low mood that can affect quality of life. If symptoms usually only occur in the winter months, it may be seasonal affective disorder (SAD), or major ...

After The White Lotus alum shared his borderline personality disorder diagnosis in his forthcoming memoir I Wrote This For Attention, he expanded on why he wanted to come forward with such a ...

Here's the uncomfortable truth: my father's rage is why I'm good at what I do. One of my earliest childhood memories is of walking slowly up the stairs above my dad's office, praying he wouldn't hear ...

In an exciting scientific first, researchers at the Allen Institute successfully designed a new gene therapy that reversed symptoms related to SYNGAP1-related disorders (SRD) in mice. These are a ...